Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethyl phenoxyacetate, an ester, is a clear yellow liquid that can undergo cyanide ion catalyzed aminolysis with ammonia to produce the corresponding amide. This chemical property makes it a versatile compound with potential applications in various industries.

2555-49-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2555-49-9 Structure
  • Basic information

    1. Product Name: Ethyl phenoxyacetate
    2. Synonyms: PHENOXYACETIC ACID ETHYL ESTER;phenoxy-aceticaciethylester;ETHYL PHENOXYACETATE;ETHYL-(2-PHENOXYACETAT);Ethylphenoxyacetate,98%;Ethyl phenoxyacetate 98%
    3. CAS NO:2555-49-9
    4. Molecular Formula: C10H12O3
    5. Molecular Weight: 180.2
    6. EINECS: 219-867-3
    7. Product Categories: Miscellaneous;C10 to C11;Carbonyl Compounds;Esters
    8. Mol File: 2555-49-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 136 °C (19 mmHg)
    3. Flash Point: >110°C
    4. Appearance: Clear yellow/Liquid
    5. Density: 1.1 g/mL at 25 °C(lit.)
    6. Vapor Pressure: 0.0246mmHg at 25°C
    7. Refractive Index: 1.5045-1.5065
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. Water Solubility: immiscible
    11. BRN: 1871712
    12. CAS DataBase Reference: Ethyl phenoxyacetate(CAS DataBase Reference)
    13. NIST Chemistry Reference: Ethyl phenoxyacetate(2555-49-9)
    14. EPA Substance Registry System: Ethyl phenoxyacetate(2555-49-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: 24/25
    4. WGK Germany: 3
    5. RTECS:
    6. TSCA: T
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 2555-49-9(Hazardous Substances Data)

2555-49-9 Usage

Uses

Used in Pharmaceutical Industry:
Ethyl phenoxyacetate is used as an intermediate in the synthesis of various pharmaceutical compounds. Its ability to form amides through aminolysis makes it a valuable building block for creating new drugs with potential therapeutic applications.
Used in Chemical Synthesis:
As an ester, Ethyl phenoxyacetate is used as a reagent in the chemical synthesis of other organic compounds. Its versatility in undergoing aminolysis reactions allows for the creation of a wide range of products, contributing to the development of new materials and chemicals.
Used in Research and Development:
Ethyl phenoxyacetate serves as a valuable compound for research and development purposes. Its unique chemical properties and reactivity make it an essential tool for scientists and researchers working on the discovery and development of new chemical processes and products.

Check Digit Verification of cas no

The CAS Registry Mumber 2555-49-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,5 and 5 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2555-49:
(6*2)+(5*5)+(4*5)+(3*5)+(2*4)+(1*9)=89
89 % 10 = 9
So 2555-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O3/c1-2-12-10(11)8-13-9-6-4-3-5-7-9/h3-7H,2,8H2,1H3

2555-49-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A14156)  Ethyl phenoxyacetate, 99%   

  • 2555-49-9

  • 10g

  • 498.0CNY

  • Detail
  • Alfa Aesar

  • (A14156)  Ethyl phenoxyacetate, 99%   

  • 2555-49-9

  • 50g

  • 1195.0CNY

  • Detail
  • Alfa Aesar

  • (A14156)  Ethyl phenoxyacetate, 99%   

  • 2555-49-9

  • 250g

  • 4742.0CNY

  • Detail

2555-49-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-phenoxyacetate

1.2 Other means of identification

Product number -
Other names Ethyl 2-phenoxyacetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2555-49-9 SDS

2555-49-9Synthetic route

ethyl bromoacetate
105-36-2

ethyl bromoacetate

phenol
108-95-2

phenol

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃; for 3h;99%
With potassium carbonate In acetone at 20℃; for 3h;99%
Stage #1: phenol With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: ethyl bromoacetate In N,N-dimethyl-formamide at 60℃; for 3h;
94%
methyl phenyl carbonate
13509-27-8

methyl phenyl carbonate

tetrabutyl phosphonium bromide
3115-68-2

tetrabutyl phosphonium bromide

chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
96%
ethyl iodide
75-03-6

ethyl iodide

2-phenoxyacetic acid
122-59-8

2-phenoxyacetic acid

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With cesium fluoride In acetonitrile for 1.5h; Heating;94%
ethanol
64-17-5

ethanol

2-phenoxyacetic acid
122-59-8

2-phenoxyacetic acid

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With sulfuric acid for 14h; Reflux;92%
sulfuric acid; silica gel In diethyl ether for 0.333333h; Heating;88%
With tris(2-methoxyphenyl)bismuthine In benzene for 12h; Heating;75%
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

phenol
108-95-2

phenol

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With copper(I) trifluoromethanesulfonate benzene; 6-[(R)-1-(1-naphthyl)ethyl]-3,9-ditosyl-3,6,9,15-tetraazabicyclo[9,3,1]pentadeca-1(15),11,13-triene In 1,2-dichloro-ethane at 20℃; for 18h; Inert atmosphere; Schlenk technique;90%
methyltrioxorhenium(VII) In benzene for 48h; Ambient temperature;87%
With [(Zr6(μ3-O)8(OH)2(H2O)10)2(Ir(tetrakis(4-carboxyphenyl)porphyrin)Cl)3]*8(C6H5COOH)*4DMF In dichloromethane at 20℃; for 0.166667h; Catalytic behavior;56%
chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

phenol
108-95-2

phenol

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate In acetonitrile88.7%
With potassium carbonate In acetone for 10h; Reflux;80%
With potassium carbonate In acetone Reflux;80%
ethanol
64-17-5

ethanol

phenoxyacetamide
621-88-5

phenoxyacetamide

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With N,N-dimethyl-formamide dimethyl acetal at 45℃; for 3h;85%
2-phenoxyacetic acid
122-59-8

2-phenoxyacetic acid

triethylphosphine
554-70-1

triethylphosphine

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With 1,3-diazido-propane In neat (no solvent) at 20℃; for 0.333333h;77%
triphenyl phosphite
101-02-0

triphenyl phosphite

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

ethyl bromoacetate
105-36-2

ethyl bromoacetate

A

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

B

ethyl (E)-3-(4-chlorophenyl)prop-2-enoate
24393-52-0

ethyl (E)-3-(4-chlorophenyl)prop-2-enoate

Conditions
ConditionsYield
With 18-crown-6 ether; dibutyl telluride; potassium carbonate In toluene at 80℃;A 69%
B 68 % Chromat.
ethyl bromoacetate
105-36-2

ethyl bromoacetate

2-methoxy-phenol
90-05-1

2-methoxy-phenol

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate In acetone for 16h; Reflux;67%
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

methoxybenzene
100-66-3

methoxybenzene

A

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

B

ethyl 4-methoxy-1,3,6-cycloheptatriene-1-carboxylate
60058-37-9

ethyl 4-methoxy-1,3,6-cycloheptatriene-1-carboxylate

C

ethyl 3-methoxy-2,5,7-cycloheptatriene-1-carboxylate
41585-58-4

ethyl 3-methoxy-2,5,7-cycloheptatriene-1-carboxylate

D

ethyl 6-methoxy-1,3,5-cycloheptatriene-1-carboxylate
41585-61-9

ethyl 6-methoxy-1,3,5-cycloheptatriene-1-carboxylate

Conditions
ConditionsYield
for 2.5h; Heating; Further byproducts given;A 8%
B 15%
C 8%
D 1%
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

methoxybenzene
100-66-3

methoxybenzene

A

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

B

ethyl 4-methoxy-1,3,6-cycloheptatriene-1-carboxylate
60058-37-9

ethyl 4-methoxy-1,3,6-cycloheptatriene-1-carboxylate

C

ethyl 3-methoxy-2,5,7-cycloheptatriene-1-carboxylate
41585-58-4

ethyl 3-methoxy-2,5,7-cycloheptatriene-1-carboxylate

D

ethyl 2-methoxy-2,4,6-cycloheptatriene-1-carboxylate
80865-81-2

ethyl 2-methoxy-2,4,6-cycloheptatriene-1-carboxylate

Conditions
ConditionsYield
for 2.5h; Heating; Further byproducts given;A 8%
B 15%
C 8%
D 2%
ethanol
64-17-5

ethanol

2-Phenoxyethansaeure-phenylester
25774-60-1

2-Phenoxyethansaeure-phenylester

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

sodium phenoxide
139-02-6

sodium phenoxide

chloroacetic acid ethyl ester
105-39-5

chloroacetic acid ethyl ester

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

sodium phenoxide
139-02-6

sodium phenoxide

ethyl bromoacetate
105-36-2

ethyl bromoacetate

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With ethanol
2-phenoxyacetic acid
122-59-8

2-phenoxyacetic acid

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With hydrogenchloride; ethanol
2-phenoxyacetic acid
122-59-8

2-phenoxyacetic acid

A

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

B

1,2-diphenoxyethane
104-66-5

1,2-diphenoxyethane

Conditions
ConditionsYield
With pyridine In ethanol (electrolysis);
2-phenoxyacetic acid sodium salt
3598-16-1

2-phenoxyacetic acid sodium salt

ethyl iodide
75-03-6

ethyl iodide

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
With IRA-400 (Cl-) 1) H2O; 2) EtOH, 5 h; Yield given. Multistep reaction;
ethyl iodide
75-03-6

ethyl iodide

tetramethylammonium phenoxyacetate

tetramethylammonium phenoxyacetate

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
In acetonitrile at 30℃; Rate constant; Thermodynamic data; ΔH(excit.), ΔS(excit.);
In acetonitrile at 30℃; Thermodynamic data;
In acetonitrile at 30℃;
2-phenoxyacetate
4421-01-6

2-phenoxyacetate

ethyl iodide
75-03-6

ethyl iodide

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
In acetonitrile at 25℃; Thermodynamic data; reaction enthalpy;
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

phenol
108-95-2

phenol

copper-powder

copper-powder

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

methoxybenzene
100-66-3

methoxybenzene

A

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

B

ethyl p-methoxyphenylacetate
14062-18-1

ethyl p-methoxyphenylacetate

C

4-methoxy-cycloheptatrienecarboxylic acid ethyl ester

4-methoxy-cycloheptatrienecarboxylic acid ethyl ester

Conditions
ConditionsYield
at 150℃;
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

methoxybenzene
100-66-3

methoxybenzene

A

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

B

ethyl p-methoxyphenylacetate
14062-18-1

ethyl p-methoxyphenylacetate

C

4-methoxy-cyclohepta-1,3,5-trienecarboxylic acid ethyl ester

4-methoxy-cyclohepta-1,3,5-trienecarboxylic acid ethyl ester

Conditions
ConditionsYield
at 154℃;
2-phenoxyacetic acid
122-59-8

2-phenoxyacetic acid

EtX

EtX

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

ethanol
64-17-5

ethanol

2-phenoxy-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone

2-phenoxy-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone

A

benzo[d]oxazole-2-(3H)-thione
2382-96-9

benzo[d]oxazole-2-(3H)-thione

B

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
In chloroform-d1 at 20℃; for 20h; Irradiation;A 64 % Spectr.
B 64 % Spectr.
ethanol
64-17-5

ethanol

N-(phenyloxyacetyl)benzothiazoline-2-thione
660390-66-9

N-(phenyloxyacetyl)benzothiazoline-2-thione

A

2-thioxo-3H-1,3-benzothiazole
149-30-4

2-thioxo-3H-1,3-benzothiazole

B

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
In chloroform-d1 at 20℃; for 3h; Irradiation;A 95 % Spectr.
B 95 % Spectr.
Phenoxyacetyl chloride
701-99-5

Phenoxyacetyl chloride

(+)-(S,R)-tricarbonyl[(1,2,3,4,5,6-η)-2-methoxy-6-(N-phenylimino)-1-naphthylbenzene]chromium

(+)-(S,R)-tricarbonyl[(1,2,3,4,5,6-η)-2-methoxy-6-(N-phenylimino)-1-naphthylbenzene]chromium

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 83 percent / Et3N / CH2Cl2; benzene / 1 h / 20 °C
2: 95 percent Spectr. / CDCl3 / 3 h / 20 °C / Irradiation
View Scheme
sodium phenoxide
139-02-6

sodium phenoxide

5-chloro-4-nitro-toluene-sulfonic acid-(2)-chloride

5-chloro-4-nitro-toluene-sulfonic acid-(2)-chloride

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

sodium phenoxide
139-02-6

sodium phenoxide

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: alcohol; hydrogen chloride
View Scheme
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

phenoxyacetyl hydrazine
4664-55-5

phenoxyacetyl hydrazine

Conditions
ConditionsYield
With hydrazine hydrate In ethanol Reflux;98%
With hydrazine hydrate In ethanol Reflux;90%
With hydrazine hydrate In ethanol at 85℃;88%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

2-Phenoxyethanol
122-99-6

2-Phenoxyethanol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In diethyl ether at 0℃; for 3h;98%
Stage #1: phenoxyacetic acid ethyl ester With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; for 4h;
Stage #2: With sodium hydroxide In tetrahydrofuran; methanol; water
88%
With lithium aluminium tetrahydride In diethyl ether at 0 - 20℃; for 2h;85%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

methyl 2-amino-4-chloro-5-iodobenzoate
199850-56-1

methyl 2-amino-4-chloro-5-iodobenzoate

7-chloro-4-hydroxy-6-iodo-3-phenoxy quinolin-2(1H)-one
1367847-06-0

7-chloro-4-hydroxy-6-iodo-3-phenoxy quinolin-2(1H)-one

Conditions
ConditionsYield
With potassium hexamethylsilazane In tetrahydrofuran at 20℃; for 0.333333h; Inert atmosphere;98%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

2-amino-6-methylbenzoic acid methyl ester
18595-13-6

2-amino-6-methylbenzoic acid methyl ester

C16H13NO3
1367847-14-0

C16H13NO3

Conditions
ConditionsYield
With potassium hexamethylsilazane In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;96%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

2-phenoxyacetic acid
122-59-8

2-phenoxyacetic acid

Conditions
ConditionsYield
With lithium hydroxide monohydrate; water at 0 - 20℃; for 12h;95%
Stage #1: phenoxyacetic acid ethyl ester With sodium hydroxide In tetrahydrofuran at 20℃; for 24h;
Stage #2: With acetic acid In tetrahydrofuran; water
94%
With sodium hydroxide In ethanol Reflux;81%
2-amino-4-chloro-benzoic acid methyl ester
5900-58-3

2-amino-4-chloro-benzoic acid methyl ester

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

7-chloro-4-hydroxy-3-phenoxyquinolin-2(1H)-one
1367846-98-7

7-chloro-4-hydroxy-3-phenoxyquinolin-2(1H)-one

Conditions
ConditionsYield
With potassium hexamethylsilazane In tetrahydrofuran at 20℃; for 0.166667h; Inert atmosphere;92%
p-benzyloxybenzaldehyde
4397-53-9

p-benzyloxybenzaldehyde

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

3-(4-benzyloxyphenyl)-2-phenoxy-3-hydroxypropionic acid ethyl ester
698347-46-5

3-(4-benzyloxyphenyl)-2-phenoxy-3-hydroxypropionic acid ethyl ester

Conditions
ConditionsYield
With n-butyllithium; diisopropylamine In tetrahydrofuran at -70 - -40℃; Inert atmosphere;91%
With lithium diisopropyl amide In tetrahydrofuran; n-heptane; toluene at -78℃; for 1h;
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

2-carbomethoxyaniline
134-20-3

2-carbomethoxyaniline

4-hydroxy-3-phenoxy-1H-quinolin-2-one
2721-55-3

4-hydroxy-3-phenoxy-1H-quinolin-2-one

Conditions
ConditionsYield
With potassium hexamethylsilazane In tetrahydrofuran at 20℃; for 0.166667h; Inert atmosphere;91%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

oxalic acid diethyl ester
95-92-1

oxalic acid diethyl ester

diethyl 2-(4-chlorophenoxy)-3-oxosuccinate
93906-72-0

diethyl 2-(4-chlorophenoxy)-3-oxosuccinate

Conditions
ConditionsYield
90%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

benzylamine
100-46-9

benzylamine

N-benzyl-2-phenoxyacetamide
18861-15-9

N-benzyl-2-phenoxyacetamide

Conditions
ConditionsYield
With iron(III) chloride In neat (no solvent) at 80℃; Sealed tube;89%
With ammonium chloride
silver tetrafluoroborate
14104-20-2

silver tetrafluoroborate

(2-methylallyl)palladium-chloride dimer

(2-methylallyl)palladium-chloride dimer

phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

[C4H7Pd(PhOCH2COOEt-κ2-O,O)]BF4
181023-60-9

[C4H7Pd(PhOCH2COOEt-κ2-O,O)]BF4

Conditions
ConditionsYield
In dichloromethane (N2); org. compd. addn. to Pd-compd. soln., stirring (30 min, room temp.), addn. to AgBF4 suspension in solvent, stirring (5 min); AgCl ppt. filtration (Celite), solvent evapn., washing (hexane), drying (vac.); elem. anal.;88%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

aniline
62-53-3

aniline

2-phenoxy-N-phenylacetamide
18705-01-6

2-phenoxy-N-phenylacetamide

Conditions
ConditionsYield
With iron(III) chloride In acetonitrile at 80℃; Sealed tube;87%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

acetyl chloride
75-36-5

acetyl chloride

A

3-methyl-4-phenoxy-1H-pyrazol-5(4H)-one
289655-92-1

3-methyl-4-phenoxy-1H-pyrazol-5(4H)-one

B

C16H14N2O3
1188445-05-7

C16H14N2O3

Conditions
ConditionsYield
Stage #1: phenoxyacetic acid ethyl ester With lithium hexamethyldisilazane In tetrahydrofuran; toluene at -78℃; for 0.5h; Claisen condensation;
Stage #2: acetyl chloride In tetrahydrofuran; toluene at -78 - -20℃; Claisen condensation;
Stage #3: With hydrazine hydrate In tetrahydrofuran; ethanol; toluene for 0.166667h; Reflux;
A 8%
B 81%
Stage #1: phenoxyacetic acid ethyl ester With lithium hexamethyldisilazane In tetrahydrofuran; toluene at -78℃; for 0.0333333h; Claisen condensation;
Stage #2: acetyl chloride In tetrahydrofuran; toluene for 0.166667h; Claisen condensation;
Stage #3: With hydrazine hydrate In tetrahydrofuran; ethanol; toluene for 0.166667h; Reflux;
A 64%
B 9%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

1,4-bis(bromomagnesium)butane
23708-47-6

1,4-bis(bromomagnesium)butane

phenoxymethylcyclopentanol
116886-12-5

phenoxymethylcyclopentanol

Conditions
ConditionsYield
In tetrahydrofuran for 1h; Ambient temperature;80%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

methyl 2-amino-4,5-dimethoxybenzoate
26759-46-6

methyl 2-amino-4,5-dimethoxybenzoate

C17H15NO5
1367847-05-9

C17H15NO5

Conditions
ConditionsYield
With potassium hexamethylsilazane In tetrahydrofuran at 20℃; for 0.5h; Inert atmosphere;80%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

5-bromo-2-aminobenzoic acid methyl ester
52727-57-8

5-bromo-2-aminobenzoic acid methyl ester

6-bromo-4-hydroxy-3-phenoxyquinolin-2(1 H)-one
1367847-12-8

6-bromo-4-hydroxy-3-phenoxyquinolin-2(1 H)-one

Conditions
ConditionsYield
With potassium hexamethylsilazane In tetrahydrofuran at 20℃; for 0.166667h; Inert atmosphere;80%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

methyl 2-amino-4-methoxybenzoate
50413-30-4

methyl 2-amino-4-methoxybenzoate

C16H13NO4
1367847-03-7

C16H13NO4

Conditions
ConditionsYield
With potassium hexamethylsilazane In tetrahydrofuran at 20℃; for 0.5h; Inert atmosphere;79%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

(4-chlorosulfonyl-phenoxy)acetic acid ethyl ester
36685-84-4

(4-chlorosulfonyl-phenoxy)acetic acid ethyl ester

Conditions
ConditionsYield
With chlorosulfonic acid In dichloromethane at 20℃; for 3h;78%
With chlorosulfonic acid at 0 - 20℃; for 2.5h;
With chlorosulfonic acid at 0 - 20℃; for 2.5h;
With chlorosulfonic acid at 0 - 20℃; for 2.5h;
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

1-benzyl-4-aminotetrahydropyridine-3-carboxylic acid methyl ester
159660-85-2

1-benzyl-4-aminotetrahydropyridine-3-carboxylic acid methyl ester

C21H20N2O3
1367847-19-5

C21H20N2O3

Conditions
ConditionsYield
With potassium hexamethylsilazane In tetrahydrofuran at 60℃; for 1h; Inert atmosphere;76%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

4-chlorobenzylamine
104-86-9

4-chlorobenzylamine

N-(4-Chloro-benzyl)-2-phenoxy-acetamide
18861-22-8

N-(4-Chloro-benzyl)-2-phenoxy-acetamide

Conditions
ConditionsYield
at 50℃; for 24h;75%
phenoxyacetic acid ethyl ester
2555-49-9

phenoxyacetic acid ethyl ester

N,N-dimethylethylenediamine
108-00-9

N,N-dimethylethylenediamine

N'-(2-phenoxyacetyl)-N,N-dimethylethylenediamine
70745-28-7

N'-(2-phenoxyacetyl)-N,N-dimethylethylenediamine

Conditions
ConditionsYield
In ethanol74.5%

2555-49-9Relevant articles and documents

Identification and synthesis of selective cholesterol esterase inhibitor using dynamic combinatorial chemistry

Zhao, Shuang,Wu, Yao,Hu, Lei

, (2021/12/04)

In this study, the concept of dynamic combinatorial chemistry (DCC) was applied to explore novel cholesterol esterase (CEase) inhibitors. In the presence of enzyme, two substrates (A1H3 and A2H3) were amplified from the dynamic combinatorial library (DCL), which was generated through reversible acylhydrazone formation reaction. In the in vitro biological evaluation, compound A1H3 exhibited not only potent (IC50 in nanomolar range) but also selective inhibition (>120 folds of selectivity for CEase over AChE). Furthermore, the binding pattern and possible binding mechanism were investigated in the kinetic experiment and molecular docking study, respectively.

Design, docking, synthesis, and characterization of novel N'(2-phenoxyacetyl) nicotinohydrazide and N'(2-phenoxyacetyl)isonicotinohydrazide derivatives as anti-inflammatory and analgesic agents

Al-Ostoot, Fares Hezam,Khanum, Shaukath Ara,M, Pallavi H,Vivek, Hamse Kameshwar

, (2021/09/14)

Inflammation is the complex biological response of vascular tissues, which is partly determined by prostaglandins (PLA2). The cyclooxygenase (COX) enzyme exists in two isoforms: COX-1 and COX-2 and by the action of this, the PGs are produced. Besides, nonsteroidal anti-inflammatory drugs (NSAIDs) are therapeutic agents useful in the treatment of inflammation. Encouraged by this, the new derivatives of N'(2-phenoxyacetyl)nicotinohydrazide 9(a-e) and N'(2-phenoxyacetyl)isonicotinohydrazide 10(a-e) were designed, synthesized, characterized, and identified as remarkable anti-inflammatory and analgesic agents. These compounds were prepared in a series of steps starting with different phenol derivatives. Among the series, compound (10e) showed the highest IC50 value for COX-1 inhibition, whereas compounds (9e) and (10e) exhibited the highest COX-2SI. Further, molecular Docking Studies have been performed for the potent compound to check the three-dimensional geometrical view of the ligand binding to the targeted enzymes.

Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs)

Linciano, Pasquale,Benedetti, Rosaria,Pinzi, Luca,Russo, Fabiana,Chianese, Ugo,Sorbi, Claudia,Altucci, Lucia,Rastelli, Giulio,Brasili, Livio,Franchini, Silvia

, (2020/11/24)

Histone Deacetylases (HDACs) are among the most attractive and interesting targets in anticancer drug discovery. The clinical relevance of HDAC inhibitors (HDACIs) is testified by four FDA-approved drugs for cancer treatment. However, one of the main drawbacks of these drugs resides in the lack of selectivity against the different HDAC isoforms, resulting in severe side effects. Thus, the identification of selective HDACIs represents an exciting challenge for medicinal chemists. HDACIs are composed of a cap group, a linker region, and a metal-binding group interacting with the catalytic zinc ion. While the cap group has been extensively investigated, less information is available about the effect of the linker on isoform selectivity. To this aim, in this work, we explored novel linker chemotypes to direct isoform selectivity. A small library of 25 hydroxamic acids with hitherto unexplored linker chemotypes was prepared. In vitro tests demonstrated that, depending on the linker type, some candidates selectively inhibit HDAC1 over HDAC6 isoform or vice versa. Docking calculations were performed to rationalize the effect of the novel linker chemotypes on biologic activity. Moreover, four compounds were able to increase the levels of acetylation of histone H3 or tubulin. These compounds were also assayed in breast cancer MCF7 cells to test their antiproliferative effect. Three compounds showed a significant reduction of cancer proliferation, representing valuable starting points for further optimization.

(Trifluoromethylselenyl)methylchalcogenyl as Emerging Fluorinated Groups: Synthesis under Photoredox Catalysis and Determination of the Lipophilicity

Grollier, Kevin,De Zordo-Banliat, Arnaud,Bourdreux, Flavien,Pegot, Bruce,Dagousset, Guillaume,Magnier, Emmanuel,Billard, Thierry

supporting information, p. 6028 - 6033 (2021/03/15)

The synthesis of molecules bearing (trifluoromethylselenyl)methylchalcogenyl groups is described via an efficient two-step strategy based on a metal-free photoredox catalyzed decarboxylative trifluoromethylselenolation with good yields up to 88 %, which raised to 98 % in flow chemistry conditions. The flow methods allowed also to scale up the reaction. The mechanism of this key reaction was studied. The physicochemical characterization of these emerging groups was performed by determining their Hansch–Leo lipophilicity parameters with high values up to 2.24. This reaction was also extended to perfluoroalkylselenolation with yields up to 95 %. Finally, this method was successfully applied to the functionalization of relevant bioactive molecules such as tocopherol or estrone derivatives.

Expedient discovery for novel antifungal leads: 1,3,4-Oxadiazole derivatives bearing a quinazolin-4(3H)-one fragment

Chai, Jianqi,Chen, Min,Jin, Fei,Kong, Xiangyi,Wang, Xiaobin,Xue, Wei,Yang, Chunlong

, (2021/08/03)

Developing novel fungicide candidates are intensively promoted by the rapid emergences of resistant fungi that outbreak on agricultural production. Aiming to discovery novel antifungal leads, a series of 1,3,4-oxadiazole derivatives bearing a quinazolin-4(3H)-one fragment were constructed for evaluating their inhibition effects against phytopathogenic fungi in vitro and in vivo. Systematically structural optimizations generated the bioactive molecule I32 that was identified as a promising inhibitor against Rhizoctonia solani with the in vivo preventative effect of 58.63% at 200 μg/mL. The observations that were captured by scanning electron microscopy and transmission electron microscopy demonstrated that the bioactive molecule I32 could induce the sprawling growth of hyphae, the local shrinkage and rupture on hyphal surfaces, the extreme swelling of vacuoles, the striking distortions on cell walls, and the reduction of mitochondria numbers. The above results provided an indispensable complement for the discovery of antifungal lead bearing a quinazolin-4(3H)-one and 1,3,4-oxadiazole fragment.

Modulation of DNA damage response by targeting ATM kinase using newly synthesized di-phenoxy acetamide (DPA) analogs to induce anti-neoplasia

Al-Ostoot, Fares Hezam,Sherapura, Ankith,Malojirao, Vikas H.,Thirusangu, Prabhu,Al-Muhimeed, Tahani I.,Khanum, Shaukath Ara,Prabhakar

, p. 1344 - 1360 (2021/06/14)

Background: Imbalance and instability in the structure of the DNA have become major characteristics of cancer. In response to DNA damage, DNA damage response (DDR) protein, ataxia telangiectasia mutated (ATM), plays a pivotal role in the modulation of regulatory regions responsible for inhibition of apoptosis, thereby neoplastic progression. Methods: A new series of DPA (7a–t) were synthesized, characterized. Anti-proliferative studies to identify the lead compound were carried out by LDH and MTT assay. Apoptosis/DNA damage was measured through FACS, Annexin-v staining, TUNEL and Comet assay. Elucidation of molecular mechanism through immunoblot and further validation of the drug effect through in vivo approaches. Results: Initial in vitro anti-proliferative screening of Compounds DPA (7a–t) against multiple cancer cell lines identified Compound DPA (7n) as a potent cytotoxic molecule with IC50 value of 4.3?μM. Down the line, in vitro and in vivo evaluation of Compound DPA (7n) inferred that it has apoptotic inducing potentiality. Further, evaluation of molecular mechanism inferred that Compound DPA (7n) effectively modulates ATM phosphorylation only, eventually altering downstream signalling pathways. Conclusions: Compound DPA (7n) emerged as a potent proapoptotic and anti-neoplastic agent by inhibiting ATM kinase activity both in vitro and in vivo. The conferring results ascertain that the drug could be developed as a new ATM kinase inhibitor with anti-cancer capacity. Graphic abstract: [Figure not available: see fulltext.]

Targeting HIF-1α by newly synthesized Indolephenoxyacetamide (IPA) analogs to induce anti-angiogenesis-mediated solid tumor suppression

Al-Ostoot, Fares Hezam,Sherapura, Ankith,V, Vigneshwaran,Basappa, Giridhara,H.K, Vivek,B.T, Prabhakar,Khanum, Shaukath Ara

, p. 1328 - 1343 (2021/05/03)

Background: Hypoxic microenvironment is a common feature of solid tumors, which leads to the promotion of cancer. The transcription factor, HIF-1α, expressed under hypoxic conditions stimulates tumor angiogenesis, favoring HIF-1α as a promising anticancer agent. On the other hand, synthetic Indolephenoxyacetamide derivatives are known for their pharmacological potentiality. With this background here, we have synthesized, characterized, and validated the new IPA (8a–n) analogs for anti-tumor activity. Methods: The new series of IPA (8a–n) were synthesized through a multi-step reaction sequence and characterized based on the different spectroscopic analysis FT-IR, 1H, 13C NMR, mass spectra, and elemental analyses. Cell-based screening of IPA (8a–n) was assessed by MTT assay. Anti-angiogenic efficacy of IPA (8k) validated through CAM, Rat corneal, tube formation and migration assay. The underlying molecular mechanism is validated through zymogram and IB studies. The in vivo anti-tumor activity was measured in the DLA solid tumor model. Results: Screening for anti-proliferative studies inferred, IPA (8k) is a lead molecule with an IC50 value of ?5?μM. Anti-angiogenic assays revealed the angiopreventive activity through inhibition of HIF-1α and modulation downstream regulatory genes, VEGF, MMPs, and P53. The results are confirmative in an in vivo solid tumor model. Conclusion: The IPA (8k) is a potent anti-proliferative molecule with anti-angiogenic activity and specifically targets HIF1α, thereby modulates its downstream regulatory genes both in vitro and in vivo. The study provides scope for new target-specific drug development against HIF-1α for the treatment of solid tumors. Graphic abstract: [Figure not available: see fulltext.].

Drastic fluorine effect: Complete reversal of the selectivity in the Au-catalyzed hydroalkoxylation reaction of fluorinated haloalkynes

Cloutier, Mélissa,Mamone, Marius,Paquin, Jean-Fran?ois

supporting information, p. 5969 - 5972 (2020/06/04)

The gold-catalyzed hydration reaction of haloalkynes is highly regioselective producing 2-halomethylketones as the sole products. Herein, we document a drastic fluorine effect where the reaction of 1-halo-3,3-difluoroalkynes as substrates leads to a complete reversal of selectivity and produces 3,3-difluoroesters as the unique products.

Design and synthesis of α-phenoxy-N-sulfonylphenyl acetamides as Trypanosoma brucei Leucyl-tRNA synthetase inhibitors

Xin, Weixiang,Li, Zezhong,Wang, Qing,Du, Jin,Zhu, Mingyan,Zhou, Huchen

, (2019/11/26)

Human African trypanosomiasis (HAT), caused by the parasitic protozoa Trypanosoma brucei, is one of the fatal diseases in tropical areas and current medicines are insufficient. Thus, development of new drugs for HAT is urgently needed. Leucyl-tRNA synthetase (LeuRS), a recently clinically validated antimicrobial target, is an attractive target for development of antitrypanosomal drugs. In this work, we report a series of α-phenoxy-N-sulfonylphenyl acetamides as T. brucei LeuRS inhibitors. The most potent compound 28g showed an IC50 of 0.70 μM which was 250-fold more potent than the starting hit compound 1. The structure-activity relationship was also discussed. These acetamides provided a new scaffold and lead compounds for the further development of clinically useful antitrypanosomal agents.

Cobalt Nanoparticles-Catalyzed Widely Applicable Successive C?C Bond Cleavage in Alcohols to Access Esters

Dai, Wen,Gao, Shuang,Li, Guosong,Luo, Huihui,Lv, Ying,Shang, Sensen,Wang, Lianyue

supporting information, p. 19268 - 19274 (2020/08/26)

Selective cleavage and functionalization of C?C bonds have important applications in organic synthesis and biomass utilization. However, functionalization of C?C bonds by controlled cleavage remains difficult and challenging because they are inert. Herein, we describe an unprecedented efficient protocol for the breaking of successive C?C bonds in alcohols to form esters with one or multiple carbon atoms less using heterogeneous cobalt nanoparticles as catalyst with dioxygen as the oxidant. A wide range of alcohols including inactive long-chain alkyl aryl alcohols undergo smoothly successive cleavage of adjacent ?(C?C)n? bonds to afford the corresponding esters. The catalyst was used for seven times without any decrease in activity. Characterization and control experiments disclose that cobalt nanoparticles are responsible for the successive cleavage of C?C bonds to achieve excellent catalytic activity, while the presence of Co-Nx has just the opposite effect. Preliminary mechanistic studies reveal that a tandem sequence reaction is involved in this process.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2555-49-9